🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 687604108 (prev. 00211Y506 )
- Market Cap
- Micro Cap
- Previous Symbol
- ABIO (changed 8/30/2024)
- Previous Name
- Arca Biopharma, Inc.
Business: Oruka Therapeutics, Inc. is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Company’s lead product candidate, Gencaro, (bucindolol hydrochloride), is an investigational, pharmacologically unique beta-blocker and mild vasodilator being developed for atrial fibrillation.
Notes: Sept. 3, 2015 -- ARCA biopharma, Inc. (ABIO) will effect a one for seven (1-7) reverse stock split of its outstanding common stock. The reverse split will be effective at the opening of business on Friday, September 4, 2015. In conjunction with the reverse split, the CUSIP number will change to 00211Y407.
Company Contact
- CEO
- Lawrence Klein
- CFO
- Jeff Dekker
- Headquarters
- 855 Oak Grove Avenue, Suite 100, Menlo Park, CA
- Phone
- 650-606-7910
- Fax
- 720-208-9261
- Investor Relations
- Alan Lada · 650-606-7910 · ir@orukatx.com